Please read and agree to the
terms and conditions
of this site.
I agree
Stream
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
cancer immunotherapy
gilead sciences
investing
life sciences
national blog main
national top stories
novartis
san francisco blog main
adaptimmune
adaptive tcr
arsenalbio
bessemer venture partners
boston
brigham and women’s hospital
cancer
car-t chimeric antigen receptor
car-t immunotherapy
cell therapy
clinical trials
computational biology
david southwell
deals
euclidean capital
gene editing
ginkgo bioworks
gv
harvard medical school
harvard university
immunotherapy
ken drazan
kleiner perkins
longwood fund
new york blog main
novartis institutes for biomedical research
novartis venture fund
osage venture partners
parker institute for cancer immunotherapy
What
better
3
×
immune
3
×
patients
3
×
cancer
cell
therapies
arsenalbio
bodies
cells
coax
despite
destroy
dialysis
doing
donor
drugs
effective
exhausting
fight
incompatible
instead
kidney
kidneys
lands
launches
lives
match
nationwide
new
organs
patient’s
programmable
progress
receptor
recognize
reject
rest
safer
spend
study
Language
unknown
unset
Current search:
immune
×
patients
×
better
×
{{ ::tile.facetWhoCard }}
{{ ::tile.pubDate | moment: 'fromNow'}}
Paste
[[item:{{::tile.id}}]]
to render this photo inside an other item's description.
PROCESSING
TRANSCODING
ERROR
EXTRACTING
ERROR
{{::tile.title}}